FDC Reports, PharmAsia News and Sidley Austin proudly present:

The Chinese Regulatory Outlook A Changing World for Drug
and Device Companies

Date:Tuesday, Dec. 16, 2008 10 AM ET / 7AM PT 90 minutes


Chen Yang
Sidley Austin LLP, Beijing

Adrian Emch
Sidley Austin LLP, Beijing

For pharmaceuticals, new requirements for electronic tracking of certain products have gone into effect, with possible expansion in 2009 to include all drugs and medical devices marketed in China.

For medical devices, SFDA has published its second draft GMP regulations, along with draft certification and inspection procedures for device products.

Are you ready to meet the challenges and opportunities presented by these regulatory changes Learn what your company must do today to comply with Chinas new drug and device regulations and policies. Plus, get a sneak peek at future regulatory changes that are on the way.

Join us for a thought-provoking analysis of this evolving paradigm live from Beijing. Grab your team, a phone and a computer with Web access (that last ones optional). No travel required.

EARLY BIRD PRICE available now through Dec. 9!

Live webinar: $299 (regular $399)
Live webinar plus complete audio recording: $399 (regular $499)
Audio recording only: $399 (regular $499)

Click here for more information and registraion.